Latest Ratings for CMS Date Firm Action From To Mar 2022 BMO Capital Maintains Outperform Mar 2022 Mizuho Maintains Buy Jan 2022 Keybanc Maintains Overweight View More Analyst Ratings for CMS View the Latest Analyst Ratings read more